DENVER, April 13, 2018 -- Elixinol, a proud member of the US Hemp Roundtable, applauds the Hemp Farming Act Bill of 2018. Introduced on April 12, 2018, the bill is a bipartisan effort sponsored by Senator Mitch McConnell (R-Ky.) and co-sponsored by Sens. Ron Wyden (D-Ore.) and Rand Paul (R-Ky.). Jamie Comer (R-Ky.) is expected to introduce a House companion bill.
|
||||||||||
Elixinol has been sourcing hemp for its CBD hemp oil products from state-approved Colorado hemp farms for the last year.
The Hemp Farming Act of 2018 allows states and Native American tribes to regulate hemp growth within their jurisdictions. Further, it makes hemp research eligible for competitive grant funding at the USDA and further protects hemp farmers by making crop insurance available.
“To remove any federal ambiguity about hemp’s legality, support the US agricultural community and reinforce hemp’s place in research is a complete home-run for American consumers,” said Chris Husong, Elixinol Director.
“Because this bill has the potential to create tens of thousands of US jobs, provide Americans with more natural food, supplement and fiber choices and revolutionize wellness in the United States, it’s not going too far to say this is one of the most positive and economically impactful Senate bills we’ve seen in years,” continued Husong.
The Senate’s Hemp Farming Act Bill of 2018 will federally define hemp as having no more than .3% THC and as such, permanently remove it from the Controlled Substances Act, enabling hemp-based products, including food, to once again be household products.
“We are overjoyed by the decision to expedite the Hemp Farming Act through Congress. We, along with many partners have worked tirelessly to reinvigorate this industry in the US,” said Gabriel Ettenson Elixinol co-founder and General Manager.
“The exciting compounds within hemp have the power to transform the health of our society and move toward environmental sustainability,” he continued.
About Elixinol:
Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products in 40 countries globally including North and South America, throughout Europe, Asia and the Pacific Region. Elixinol’s parent company Elixinol Global (elixinolglobal.com) is publicly traded under EXL. More information available at Elixinol.com.
Photos accompanying this announcement are available at http://resource.globenewswire.com/Resource/Download/f92626e9-0cbc-43e5-9f4f-1a80f5eb6194
http://resource.globenewswire.com/Resource/Download/e5741502-72fa-4811-9e53-e6b284c7e0d1
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]


Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Same sparkle, different story: how lab-grown diamonds are transforming the market
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
World game at war: why some European nations have threatened a World Cup boycott
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 



